Novolog (Pharm-Up 1966) Ltd (TLV: NVLG)

Novolog (Pharm-Up 1966) Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	234.51	232.94	172.81	238.71	176.44	185.11
Cash & Short-Term Investments	234.51	232.94	172.81	238.71	176.44	185.11
Cash Growth	-26.85%	34.80%	-27.61%	35.29%	-4.68%	71.45%
Accounts Receivable	1,651	1,560	1,310	1,286	1,260	1,247
Other Receivables	38.83	53.43	36.54	20.28	10.99	25.66
Receivables	1,689	1,613	1,346	1,306	1,271	1,272
Inventory	226.7	247.33	189.03	186.79	255.64	214.55
Prepaid Expenses	-	11.35	9.56	10.25	4.68	3.59
Other Current Assets	-	1.86	0.76	-	-	-
Total Current Assets	2,151	2,106	1,719	1,742	1,708	1,675
Property, Plant & Equipment	308.42	321.4	306.62	224.77	191.24	220.13
Long-Term Investments	16	16.2	42.31	23.4	0.5	0.5
Goodwill	162.69	162.69	206.96	161.06	144.91	135.71
Other Intangible Assets	146.81	138.43	121.92	97.4	75.78	75.83
Long-Term Accounts Receivable	28.15	29.62	32.15	33.94	34.93	7.74
Long-Term Deferred Tax Assets	4.65	4.82	1.78	0.77	1.04	0.29
Other Long-Term Assets	10.42	9	6.29	5.04	30.2	34.59
Total Assets	2,828	2,789	2,437	2,289	2,187	2,150
Accounts Payable	2,136	2,079	1,662	1,616	1,663	1,660
Accrued Expenses	-	56.53	49.43	43.48	32.97	29.57
Current Portion of Long-Term Debt	0.13	0.91	1.15	0.39	0.06	0.06
Current Portion of Leases	26.34	26.6	22.06	20.14	16.2	16.37
Current Income Taxes Payable	5.53	6.55	6.52	4.59	2.61	1
Other Current Liabilities	66.7	15.65	13.42	4.3	18.39	7.04
Total Current Liabilities	2,234	2,185	1,754	1,689	1,734	1,714
Long-Term Debt	-	0.07	0.97	0.92	0.43	0.5
Long-Term Leases	180.35	187.59	188.6	145.37	137.54	141.09
Long-Term Deferred Tax Liabilities	14.98	16.41	19.71	17.63	16.22	16.78
Other Long-Term Liabilities	1.69	1.69	6.46	1.42	0.5	11.6
Total Liabilities	2,433	2,392	1,972	1,858	1,891	1,886
Common Stock	5.11	5.11	5.09	5.07	4.64	4.64
Additional Paid-In Capital	347.07	345.07	340.97	339.73	218.91	218.83
Retained Earnings	42.93	32.67	91.58	75.97	65.65	37.58
Comprensive Income & Other	-15.47	-11.77	-1.93	3.61	5.49	2.74
Total Common Equity	379.63	371.08	435.7	424.37	294.69	263.78
Minority Interest	15.1	25.04	28.78	5.86	0.98	-
Shareholders' Equity	394.73	396.12	464.48	430.23	295.67	263.78
Total Liabilities & Equity	2,828	2,789	2,437	2,289	2,187	2,150
Total Debt	206.82	215.18	212.77	166.81	154.24	158.02
Net Cash (Debt)	27.69	17.76	-39.97	71.9	22.2	27.09
Net Cash Growth	-75.53%	-	-	223.81%	-18.03%	-74.77%
Net Cash Per Share	0.05	0.03	-0.08	0.14	0.05	0.07
Filing Date Shares Outstanding	510.72	510.72	508.7	506.57	463.49	463.49
Total Common Shares Outstanding	510.72	510.72	508.7	506.57	463.49	463.49
Working Capital	-83.65	-78.39	-35.81	52.94	-25.64	-38.12
Book Value Per Share	0.74	0.73	0.86	0.84	0.64	0.57
Tangible Book Value	70.14	69.97	106.82	165.91	74	52.23
Tangible Book Value Per Share	0.14	0.14	0.21	0.33	0.16	0.11
Machinery	-	148.01	131.88	155.63	133.06	141.13
Leasehold Improvements	-	131.41	113.03	74.47	71	66.27

Source: S&P Capital IQ. Standard template. Financial Sources.